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Abstract
Identification of epitopes that invoke strong responses from B-cells is one of the key steps in designing effective
vaccines against pathogens. Because experimental determination of epitopes is expensive in terms of cost, time,
and effort involved, there is an urgent need for computational methods for reliable identification of B-cell epitopes.
Although several computational tools for predicting B-cell epitopes have become available in recent years, the pre-
dictive performance of existing tools remains far from ideal. We review recent advances in computational methods
for B-cell epitope prediction, identify some gaps in the current state of the art, and outline some promising direc-
tions for improving the reliability of such methods.
Review
Antigen-antibody interactions play a pivotal role in the
humoral immune response. Antibodies bind to antigens
at specific sites which correspond to the antigenic deter-
minants or B-cell epitopes. Identification and characteri-
zation of B-cell epitopes in target antigens is one of the
key steps in epitope-driven vaccine design, immunodiag-
nostic tests, and antibody production. B-cell epitopes
typically belong to one of two classes: linear (continuous
or sequential) epitopes or conformational (discontinu-
ous) epitopes. Linear epitopes are short peptides that
correspond to a contiguous amino acid sequence frag-
ment of a protein [1,2]. Linear epitopes are usually iden-
tified using assays such as PEPSCAN. Consequently,
current experimental methods offer little direct evidence
indicating that each residue in the epitope does in fact
make contact with one or more residues in the paratope
(the part in the antibody that binds to the antigen) [3].
Conformational epitopes are composed of amino acids
that although not contiguous in primary sequence, are
brought into close proximity within the folded 3-dimen-
sional protein structure. Most B-cell epitopes, although
they are composed of short linear peptides, appear to be
conformational epitopes.
Several experimental techniques are currently available
for experimental mapping of B-cell epitopes [4]. How-
ever, the high cost and effort involved makes them
impractical for application on a genomic scale. Compu-
tational techniques offer a fast, scalable, and cost-effec-
tive approach for predicting B-cell epitopes, for focusing
experimental investigations and for improving our
understanding of antigen-antibody interactions. Hence,
there is a growing interest in the development of sophis-
ticated computational tools for reliable prediction of
B-cell epitopes.
Several computational methods for B-cell epitope pre-
diction have been developed in recent years (e.g.,
[5-14]). However, the predictive performance of current
methods is far from ideal [15]. To complicate matters,
immunogenicity of proteins is poorly understood [16]
and whether B-cell epitopes could be deciphered as an
intrinsic features of the protein remains an open ques-
tion [17]. Recent studies have pointed out some of the
limitations of current epitope prediction methods
[6,17,18]. Hence, increasing the reliability of computa-
tional methods for B-cell epitope prediction remains a
major challenge in computational vaccinology [19]. In
2007, the National Institute of Allergy and Infectious
Diseases (NIAID) sponsored a workshop and a meeting
of a panel of immunologists and bioinformaticians in
order to assess the current state of the art in epitope
prediction and to identify some areas for further
research [15]. One of the key goals of the workshop was
to facilitate and expedite the development of improved
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methods for B-cell epitope prediction. The report from
the workshop recommended (among other things)
developing benchmark datasets, standardizing the data
formats, and identifying suitable performance metrics
for comparing alternative methods.
Against this background, we review recent advances in
computational methods for B-cell epitope prediction,
identify some gaps in the current state of the art, and
outline some promising directions for improving the
reliability of such methods.
Predicting linear B-cell epitopes
Although it is believed that the majority of B-cell epi-
topes are conformational epitopes [20], experimental
determination of epitopes has focused primarily on the
identification of linear B-cell epitopes [21]. However,
even in the case of linear B-cell epitopes, antibody-
antigen interactions are often conformation-dependent.
The conformation-dependent nature of antigen-antibody
binding complicates the problem of B-cell epitope pre-
diction. Hence, B-cell epitope prediction is less tractable
than T-cell epitope prediction [22]. In what follows, we
review the major approaches for predicting linear B-cell
epitopes.
Propensity scale methods
Propensity scale methods [23-26] assign a propensity
value to each amino acid which measures the tendency
of an amino acid to be part of a B-cell epitope (as com-
pared to the background). To reduce fluctuations, the
score for each target amino acid residue in a query
sequence is computed as the average of the propensity
values of the amino acids in a sliding window centered
at the target residue. The propensity scores are then
used as a basis of predicting whether a given amino acid
sequence residue is likely to be part of a linear B-cell
epitope. Propensity scale based methods rely on the
observed correlations between specific physico-chemical
properties of amino acids and the antigenic determi-
nants in protein sequences to identify the location of
the linear B-cell epitopes in the query protein sequence.
The first propensity scale method for predicting linear
B-cell epitopes was introduced by Hopp and Woods
[27] and utilized Levitt hydorophilicity scale [28] to
assign a propensity value to each amino acid. This
method is based on the assumption that antigenic deter-
minants of protein sequences correspond typically to
sequence windows that contain a large number of
charged and polar residues and lack large hydrophilic
residues.
Subsequently, several other propensity scales have
been proposed for predicting linear B-cell epitopes. For
example, Parker et al. [23], Karplus et al. [24], Pellequer
et al. [29] and Emini et al. [26] have proposed propen-
sity scale based methods that use hydrophilicity,
flexibility, turns, or solvent accessibility propensity scales
(respectively). PREDITOP [25], PEOPLE [30], BEPI-
TOPE [31], and BcePred [32] predict linear B-cell epi-
topes based on combinations of physico-chemical
properties as opposed to propensity measures that rely
on individual properties.
Recently, Blythe and Flower [18] have performed an
exhaustive assessment of 484 amino acid propensity
scales to examine the correlation between propensity
scale-based profiles and the location of linear B-cell epi-
topes in a dataset of 50 proteins. Their study found that
even the best combinations of amino acid propensities
yielded B-cell epitope predictions that were only mar-
ginally better than chance. The study concluded that the
performance of propensity scale based methods reported
in the literature is likely to have been overly optimistic,
in part due to the small size of the datasets on which
the methods had been evaluated. They suggested that
more sophisticated approaches (i.e., machine learning
approaches) for predicting linear B-cell epitopes need to
be developed and rigorously evaluated in order to
advance the state-of-the-art in linear B-cell epitope
prediction.
Improved propensity scale methods
Several authors have explored methods for improving
the predictive performance of propensity scale methods
in predicting linear B-cell epitopes. BepiPred [11] com-
bines the hydorophilicity scale constructed by Parker
et al. [23] with a Hidden Markov Model (HMM) and
demonstrates a slight but statistically significant
improvement in performance over the propensity scale
based methods of Parker et al. [23] and Levitt et al. [28]
on a test dataset of 14 proteins and 83 epitopes. Chen
et al. [8] have developed an amino acid pair (AAP) anti-
genicity scale that assigns to each possible pair of amino
acids (i.e., dipeptides), a propensity value. The resulting
AAP propensities are then used to represent each pep-
tide sequence using 400 features. Chen et al. [8] trained
and evaluated a support vector machine (SVM) classifier
using this representation on a dataset of 872 unique epi-
topes and 872 non-epitopes. They found that the SVM
classifiers trained using amino acid pair (AAP) propen-
sity derived features outperform SVM classifiers trained
using amino acid propensity derived features.
Machine learning methods
Motivated by the findings of Blythe and Flower [18] and
the increasing numbers of experimentally characterized
linear B-cell epitopes, several authors have explored
machine learning based methods for predicting linear
B-cell epitopes using amino acid sequence information.
ABCPred [12] uses recurrent artificial neural networks
for predicting linear B-cell epitopes and was evaluated
on a dataset of 700 B-cell epitopes and 700 non-epitope
peptides using 5-fold cross validation tests. Input
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sequence windows ranging from 10 to 20 amino acids
flanking the target residue, were tested and the best per-
formance, 66% accuracy, was obtained using a window
size of 16 amino acids. Söllner and Mayer [13] represent
each peptide using a set of 1487 features derived from a
variety of propensity scales, neighborhood matrices, and
respective probability and likelihood values. Among the
machine learning methods explored, they found that the
best performing method, a nearest-neighbor classifier
combined with feature selection, attained an accuracy of
72% on a dataset of 1211 B-cell epitopes and 1211 non-
epitopes using a 5-fold cross validation test [13]. BCPred
[5] and FBCPred [10] predicts linear B-cell epitopes and
flexible length linear B-cell epitopes (respectively) using
support vector machine (SVM) classifiers that use string
kernels [33]. COBEpro [34] uses a two-step procedure
for predicting linear B-cell epitopes. In the first step, an
SVM classifier is used to assign scores to fragments of
the query antigen. The input of the SVM is a vector of
similarities between the input fragment and all training
peptide fragments. In the second step, a prediction
score is associated with each residue in the query anti-
gen based on the SVM scores for the peptide fragments.
Using several benchmark datasets, COBEpro has been
shown to achieve a competitive performance with other
linear B-cell epitope prediction methods.
Predicting conformational B-cell epitopes
Although more than 90% of B-cell epitopes are esti-
mated to be conformational in nature [20], most experi-
mental as well as computational methods focus on
mapping linear B-cell epitopes. However, in the past few
years, there is increasing interest in methods for predict-
ing conformational B-cell epitopes. In what follows, we
review three major approaches for predicting conforma-
tional B-cell epitopes.
Sequence-based prediction methods
Sequence-based methods in predicting conformational
B-cell epitopes have the advantage that they do not
require the structure of the target antigen to be known.
The amino acid propensity scale methods that assign a
prediction score to each residue in the antigen sequence
can in principle be used to predict conformational
B-cell epitopes [9]. Such methods provide a baseline for
evaluation of more sophisticated conformational B-cell
epitope prediction methods.
A large body of work using machine learning methods
for predicting protein-protein [35,36], protein-DNA
[37,38], and protein-RNA [39,40] interfaces using
sequence-derived features has demonstrated the feasibil-
ity of using sequence-based classifiers in reliably identi-
fying functionally important sites in proteins. It would
be interesting to explore similar sequence-based
machine learning methods for reliable prediction of
conformational B-cell epitopes. The development of
such B-cell epitope predictors would make it feasible to
identify conformational B-cell epitopes in antigenic
sequences for which no solved 3D structures are
available.
Structure-based prediction methods
The most accurate experimental method for identifying
conformational B-cell epitopes relies on determination
of the structure of antigen-antibody complexes using
X-ray crystallography [41,42]. Because the number of
solved antigen-antibody complexes, or for that matter,
the solved antigen structures, is small relative to the
number of available antigenic sequences, there are only
a small number of methods that utilize 3D structure-
derived information in predicting conformational B-cell
epitopes.
One of the first conformational B-cell epitope predic-
tors is the conformational epitope predictor (CEP) [7].
Given an antigen with a known structure, CEP uses
accessibility of residues and spatial distance cut-off to
predict linear and conformational B-cell epitopes.
DiscoTope, a method developed by Andersen et al.
[9], uses a combination of amino acid statistics, spatial
context, and surface accessibility of amino acids to pre-
dict conformational B-cell epitopes. Dis coTope has
been shown to outperform propensity scale methods on
a dataset of 76 antigen-antibody complexes. The same
study also showed that predictors that combine both
sequence and structure-derived features of antigens are
more accurate than those that rely on either sequence
or structure derived features alone [9].
The B-cell conformational epitope predictor proposed
by Rapberger et al. [43] works as follows (given the 3D
structure of a query antigen): (i) Fast atomic density eva-
luation (FADE) [44] is applied to select an antibody
among a library of 26 available antibodies showing best
shape complementarity to the target antigen; (ii) Fas-
tContact algorithm [45] is used to identify the most likely
interaction site between the selected antibody and the
target antigen; (iii) Antigen residues that show a decrease
in relative solvent accessible surface area (estimated
using a probe size of 3Å) of at least 20% in the complex
are predicted as belonging to a discontinuous epitope.
This method was shown to outperform the CEP method
[7] using a non-redundant dataset of 26 antigen-antibody
complexes from Protein Data Bank (PDB) [46].
Ponomarenko et al. [17] introduced a benchmark data
set of 62 antibody-antigen complexes extracted from
PDB and used it to compare two conformational B-cell
epitope prediction servers (CEP and DiscoTope ) with
six publicly available web servers for protein-protein
binding site prediction using various approaches: i) pro-
tein-protein docking (ClusPro [47], DOT [48] and
PatchDock [49]); ii) structure-based methods applying
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different principals and trained on different datasets
(PPI-PRED [50], PIER [51] and ProMate [52]); iii) resi-
due conservation (ConSurf [53]). Their results suggest
that docking methods outperform other methods when
the top ten models and bound docking were considered.
However, the overall performance was found to be rela-
tively poor (with an average AUC no greater than 0.7)
for all of the methods considered.
Ellipro, a conformational B-cell epitope predictor
developed by Ponomarenko et al. [54], implements a
modified version of a method that was originally intro-
duced by Thornton et al. [55] for predicting linear
B-cell epitopes. Ellipro approximates a protein surface
patch by an ellipsoid. Then, a protrusion index is
assigned to each residue in the patch the residues are
clustered according to their protrusion index values.
The resulting clusters are predicted to be part of a con-
formational B-cell epitope. Ponomarenko et al. [54]
reported that Ellipro outperforms six other structure-
based predictors of protein-protein interfaces on a data-
set of 39 PDB antibody-antigen complexes.
PEPITO, a method for predicting conformational
B-cell epitopes introduced by Sweredoski and Baldi [56],
uses a weighted linear combination of amino acid pro-
pensity scores and half sphere exposure values [57]
which encode side chain orientation and solvent accessi-
bility of amino acid residues. An improvement in perfor-
mance over DiscoTope method has been reported [56].
Rubinstein et al. [58] explored the closely related pro-
blem of discriminating the antigenic determinant of an
antigen from the rest of the antigen surface. They car-
ried out an analysis of a non-redundant dataset of 53
antigen-antibody complexes. The results of their analysis
suggest that epitopes can be discriminated from the rest
of the antigen surface using features such as amino acid
preferences, compositions of secondary structure, geo-
metrical shape, and evolutionary conservation.
Mimotope analysis -based prediction methods
Pizzi et al. [59] have proposed an approach that com-
bines both experimental and computational techniques
for mapping B-cell epitopes. In this approach, a phage-
display library of random peptides is scanned against
an antibody of interest to obtain a panel of peptides
(called mimotopes) that bind to the antibody with high
affinity. It is assumed that this panel of mimotopes
mimics the physico-chemical properties and spatial
organization of the genuine epitopes. However, the
precise identification of the epitope mimicked by the
set of mimotopes is not straightforward since the epi-
tope is often discontinuous (conformational) and the
epitope and mimotopes do not necessarily share a high
degree of sequence similarity. Moreover, some of the
mimotopes may reflect noisy biological observations
and should be filtered out in the analysis. Hence,
several computational methods have been proposed for
localizing the panel of affinity-selected peptides on the
surface of a target antigen have been proposed in lit-
erature [60-65].
In general, mimotope analysis methods available in the
literature differ from each other in terms of: i) how they
represent the antigen structure/sequence; ii) how they
align mimotopes with the target antigen structure/
sequence; iii) how they cluster the mimotopes and rank
the predicted epitopes. For example, PepSurf [63,64]
represents the target antigen as a surface graph, wherein
the nodes denote surface residues and an edge connects
two nodes if the distance between the corresponding
residues is lower than a specified threshold. Each mimo-
tope is then aligned to the surface graph using a
dynamic programming algorithm in order to obtain a
highest scoring path in the graph. The set of highest
scoring paths that are connected to each other corre-
spond to the predicted conformational B-cell epitope.
SiteLight [60] divides the antigen surface into overlap-
ping patches and then aligns each mimotope with each
patch based on a maximal bipartite matching algorithm.
Mapitope [62] extracts amino acid pairs (AAPs) from
mimotopes and the most statistically significant pairs
(SSPs) are identified. These are then mapped on the sur-
face of the antigen and the most elaborate and diverse
clusters are identified. These are regarded as the pre-
dicted epitope candidates.
Current developments and promising directions
In this section, we highlight recent developments,
ongoing efforts, and some promising directions for
developing reliable B-cell epitope prediction methods.
Predicting protective linear B-cell epitopes
Söllner et al. [14] have recently investigated the utility of
predicted antigenicity, sequence variability, and conser-
vation of post-translational-modification motifs in pre-
dicting protective linear B-cell epitopes, i.e., linear B-cell
epitopes associated with biological activity. Their analy-
sis showed that focusing on a subset of domains in the
query protein sequence (e.g., conserved regions and
regions lacking post-translational modification sites) can
potentially improve the predictive performance of linear
B-cell epitope prediction methods. El-Manzalawy et al.
[6] have recently shown that a Naive Bayes classifier
trained using evolutionary information (e.g., Position
specific scoring matrix (PSSM) profiles obtained using
PSI-BLAST [66]) outperforms propensity scale based
methods in predicting protective linear B-cell epitopes.
These results suggest the possibility of improving the
performance of B-cell epitope prediction methods by
designing classifiers that are trained on specific sub-
classes of B-cell epitopes (e.g., protective or neutralizing
epitopes).
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Hybrid and consensus predictions of B-cell epitopes
Ensemble methods that combine the predictions of sev-
eral predictors often outperform individual predictors in
many biomolecular sequence and structure classification
tasks [67-71]. Several strategies for combining a set of
predictors, S, into a single consensus or meta predictor
exist: (i) majority voting: the score for consensus predic-
tion is obtained by the averaging the predicted scores of
the individual predictors in S; (ii) weighted linear combi-
nation: the consensus prediction is obtained via a
weighted sum of the predictions obtained from the pre-
dictors in S. The weights can be assigned based on the
estimated performance of the predictors on a training
dataset, or optimized to minimize the prediction error
of the combined predictors on a training dataset; (iii)
meta-learning: A meta-classifier is trained on a training
dataset using the outputs of the predictors in S on each
input sample as input to the classifier and the corre-
sponding class label as the desired output of the
classifier.
Recently, Söllner [72] introduced an approach for
developing an ensemble of linear B-cell epitope classi-
fiers. Initially, a large number of nearest neighbor and
decision tree based classifies trained using different sets
of training data features has been created. A strategy
based on comparing Receiver Operating Characteristic
(ROC) curves of classifiers was applied to select optimal
performing classifiers. Finally, an ensemble of the opti-
mal performing classifiers was developed based on a
proposed majority voting strategy, positive unanimity
voting. Simply, a positive prediction is accepted if and
only if all the classifiers forming the ensemble returned
a positive prediction.
Improved conformational B-cell epitope prediction tools
Antigen-antibody interactions constitute a subtype of
protein-protein interactions. Therefore, the development
of improved conformational B-cell epitope prediction
tools may benefit from recent advances in developing
protein-protein interface residue prediction methods.
Hence, it would be interesting to explore the develop-
ment of conformational B-cell epitope predictors that
utilize or adapt sophisticated protein-protein interface
predictors e.g., those that make use of sequence and
structure-derived features, analyses of surface patches
[51,73,74] shape descriptors [75,76] or docking [77].
Immune epitope database and analysis resources
The immune epitope database (IEDB) [78,79] is perhaps
the most comprehensive database of experimentally
characterized B-cell and T-cell epitopes. IEDB provides
users with access to several epitope-related analysis and
prediction tools including: (i) several methods for pre-
dicting linear and conformational B-cell epitopes; (ii) a
tool for visualizing the predicted conformational epi-
topes on the 3D structure of an antigen; (iii) several
tools for analyzing epitope data (e.g., computing epitope
conservation and epitope population coverage). IEDB
allows users to retrieve both intrinsic biochemical and
extrinsic context dependent information about epitopes
[78]. This makes it possible to easily assemble custo-
mized datasets (e.g., the protectivity data set [14]). Addi-
tionally, several researchers have utilized IEDB to
conduct meta-analyses of pathogens of interest [80-82],
thereby further enhancing the utility of IEDB in the ana-
lysis and prediction of B-cell epitopes.
Critical assessment of B-cell epitope prediction methods
Given the large number of B-cell epitope prediction
methods available, there is an urgent need for systematic
assessment of different methods on standard benchmark
datasets [15]. In practice, it is not easy to compare dif-
ferent methods because of several factors: inadequate
documentation of the datasets, prediction methods, or
the evaluation methodology employed; the unavailability
of the benchmark datasets used to evaluate the methods;
the unavailability of the code that implements the
method (especially in the case of predictors trained
using machine learning) as opposed to a server that
accepts an antigen sequence or structure as input and
outputs the predicted epitopes (fair comparison of alter-
native machine learning methods or data representations
needs to be based on the same training and test data-
sets); differences in data formats used for inputs and
outputs of the predictors.
Rigorous comparative analyses of alternative methods
are indispensible for improving our understanding of
the strengths and weaknesses of different B-cell epitope
prediction methods and for expediting the development
of improved methods. Such critical assessment of alter-
native methods has proven quite valuable in other tasks
e.g., protein structure prediction [83], protein-protein
interaction site prediction [84].
The development of standardized data representations
that would allow different prediction methods to be
evaluated on standardized benchmark datasets would be
extremely useful not only for comparing the methods
but also for developing meta-servers combining the pre-
dictions of several prediction tools [15].
The Epitopes Toolkit (EpiT) [85] represents an
attempt at standardizing the development and compari-
son of alternative epitope prediction methods. EpiT
standardizes not only the data input and output formats
for the predictors but also the encoding of the predic-
tors themselves as serialized Java objects (model files)
that can be executed within the EpiT environment.
EpiT consists of two main components: i) model
builder, an application for building and evaluating epi-
tope predictors and serializing these models in a binary
format (model files). This application is an extension of
WEKA [86], a widely used open source machine
EL-Manzalawy and Honavar Immunome Research 2010, 6(Suppl 2):S2
http://www.immunome-research.com/content/6/S2/S2
Page 5 of 9
learning toolkit that includes implementations of several
machine learning algorithms. WEKA provides tools for
data pre-processing, classification, regression, clustering,
validation, and visualization. Furthermore, WEKA pro-
vides a framework for implementing new machine learn-
ing methods and data pre-processors; ii) predictor, an
application for applying a model to test data (e.g., set of
epitopes or protein sequences).
EpiT is implemented in Java (and modulo the choice
of the Java platform, platform-independent). EpiT can
be freely downloaded from the project web site at
http://ailab.cs.iastate.edu/epit. In addition, the project
web site offers a rich resource for the developers of epi-
tope prediction tools and for EpiT users. Some examples
of the useful resources available at the EpiT project web
site include:
● EpiT documentation: A tutorial and an API docu-
mentation of EpiT components that includes several
examples of how to build an epitope predictor and
how to build an ensemble or a consensus predictor.
● An expanding Repository of Epitope Predictors
(REP): Ready to use models for predicting linear
B-cell epitopes using BCPred [5], FBCPred [10], and
AAP [8] methods. Other researchers can contribute
new epitope predictors to this repository.
● A Repository of Epitope Datasets (RED): A reposi-
tory of epitope benchmark datasets made available
by the authors as well as several other publicly avail-
able datasets (in WEKA format) that can be used by
EpiT users to build their own customized epitope
prediction tools. Researchers can contribute addi-
tional benchmark datasets to the repository.
EpiT toolkit is available under the GNU General Pub-
lic License (GPL) which allows others to freely extend
or modify the software so long as the modified software
is also made available under the GNU GPL.
Conclusions
Developing improved methods for predicting B-cell
epitopes requires large datasets of experimentally well-
characterized B-cell epitopes, and especially, antigen-
antibody complexes and protective epitopes. Special care
must be exercised to ensure that the datasets used to
train and evaluate the predictors are of high quality:
● Constructing Non-Redundant datasets: Redundant
antibody-antigen complexes should be eliminated
from the datasets of B-cell epitopes used to train
and evaluate B-cell epitope predictors. Otherwise,
the estimated performance of predictors can be
overly optimistic due to presence of similar com-
plexes in both the training and test datasets. Most of
existing linear B-cell epitope datasets [11,13,87] con-
sist of unique epitopes. However, the uniqueness of
epitope sequences is not a sufficient condition for
non-redundancy of the dataset because a pair of
unique linear B-cell epitopes can share a high degree
of pairwise sequence similarity. Unless additional
similarity reduction steps are taken to eliminate
similar epitopes from the dataset, the predictive per-
formance of B-cell epitope predictors estimated
using cross-validation on such datasets can be overly
optimistic; and in some cases, lead to false conclu-
sions regarding the performance of different predic-
tors (or the machine learning algorithms used to
train the corresponding predictors) relative to each
other [10].
● Identifying Non-epitope data: In the currently
available conformational B-cell epitope datasets
[9,17], the antigen residues that are not part of an
antibody-antigen interface in the complex are treated
as “non-epitope” residues. However, because each
antigen can potentially bind to multiple antibodies,
it is possible that some of the “non-epitope” residues
may in fact be epitope residues in the complex(s)
formed by the same antigen with other antibodies.
In currently available linear B-cell epitope datasets
comprised of whole antigen sequences [14,88], the
antigen residues that are not covered by any of the
reported epitope are treated as “non-epitope” resi-
dues. Because the experimental data available are
necessarily incomplete, some of these “non-epitope”
residues might in fact be epitope residues. Training
an epitope predictor using a dataset in which some
epitope residues are incorrectly labeled as non-
epitope residues is tantamount to training the pre-
dictor on a noisy dataset. Performance estimates of
the predictors on such a dataset tend to exaggerate
the number of false positives (and hence the esti-
mates of predictor performance that are based on
the numbers of false positives, true positives, false
negatives, and true negatives). Some authors
[5,8,10,12,13] have tried to alleviate this problem by
using non-epitope residues extracted from a random
sample of the protein sequences in SwissProt [89].
However, a recent study [34] has shown that the
resulting datasets may yield somewhat biased perfor-
mance estimates. This underscores the importance
for large experimentally well-characterized datasets
in this field.
The use of large, non-redundant, and experimentally
well-characterized datasets can help increase the accu-
racy of the cross-validation based estimates of the per-
formance of B-cell epitope predictors trained on such
datasets. However, it does not necessarily inform the
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choice of performance measures to use for comparing
different predictors (or the machine learning algorithms
used to train the predictors). Accuracy, sensitivity, speci-
ficity, and correlation coefficients are widely used
metrics for evaluating the performance of prediction
methods [90]. None of these measures when used alone
provides a complete picture of the performance of the
predictor. Each of these metrics is threshold-dependent
because it describes the performance of the predictor
for a given choice of the classification threshold. More-
over, it is possible to trade off one measure (e.g., sensi-
tivity) against another (e.g., specificity). To get a more
comprehensive picture of the performance of the predic-
tor, it is useful to consider the Receiver Operating Char-
acteristic (ROC) curve which describes the performance
of the classifier over all possible choices of the classifica-
tion threshold. The ROC curve is obtained by plotting
the true positive rate as a function of the false positive
rate or, equivalently, sensitivity versus (1-specificity) as
the discrimination threshold of the binary classifier is
varied. Each point on the ROC curve corresponds to a
specific choice of the classification threshold, and hence
a particular choice of the tradeoff between true positive
rate and false positive rate. The area under ROC curve
(AUC) is a useful threshold-independent summary sta-
tistic for comparing two ROC curves. The AUC is
defined as the probability that a randomly chosen posi-
tive sample will be ranked higher than a randomly cho-
sen negative sample. An AUC = 1 corresponds to a
perfect predictor, whereas an AUC = 0.5 corresponds to
a predictor that classifies each input sample by ran-
domly guessing its class label. Any predictor with a per-
formance that is better than random will have an AUC
value that lies between 0.5 and 1.0. AUC is one of the
most widely used metrics for comparing the perfor-
mance of different B-cell epitope predictors. It is also
the recommended metric for assessing the performance
of B-cell epitope predictors [15]. However, a comparison
of predictors based on AUC can yield misleading con-
clusions when the corresponding ROC curves cross. A
recent study [91] has shown that AUC has a more
severe limitation: Using AUC to compare different pre-
dictors is tantamount to using different misclassification
cost distributions and hence different metrics to evalu-
ate different predictors. Because the cost of misclassify-
ing a sample is a property of the prediction problem,
and not a property of the classifier, there is a need for
better metrics for fair comparison of the performance of
different predictors.
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